84-2144-02 LPAR3 (EDG7, Edg-7, LPA Receptor 3, HOFNH30, LPA3, RP4-678I3, LP-A3, LPA Receptor EDG7, LPA-3) 50ug 170915
特徴
- EDG7, a Lysophospholipid/Lysosphingolipid Receptor, was identified by RT-PCR from Jurkat T-cells.
- It is activated by unsaturated lysophosphatidic acid LPA.
- Applications:Suitable for use in Immunohistochemistry.
- Other applications not tested.
- Recommended Dilution:Immunohistochemistry (Formalin fixed paraffin embedded): 4ug/mlOptimal dilutions to be determined by the researcher.
- Storage and Stability:May be stored at 4°C for short-term only.
- Aliquot to avoid repeated freezing and thawing.
- Store at -20°C.
- Aliquots are stable for 12 months after receipt.
- For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap.
仕様
- Size：50ug
- Host：rabbit
- Source Antibody：human
- Grade：Affinity Purified
- Purity：Purified by immunoaffinity chromatography.
- Form：Supplied as a liquid in PBS, 0.09% sodium azide.
- Specificity：Recognizes human EDG7. Species crossreactivity: bat, gibbon, bovine, canine, gorilla, equine and mouse.
- Isotype：IgG
- Calc Applications Abbrev：IHC
- Calc Crossreactivity：Bo Ca Eq Hu Mo
- Immunogen：Synthetic peptide corresponding to 15aa from 2nd cytoplasmic domain of human EDG7. Species sequence homology: monkey, rat and hamster.
- Shelf Life：1year
- Swiss Prot Number：Q9UBY5
- EU Commodity Code：30021010
- この商品は法規制を確認しておりません。（法規制によって販売できない場合もございます）
- 製品の仕様は予告なく変更になる場合がございます。最新仕様はメーカーホームページをご確認ください。
- 【試薬に関するお問合せ】
- アズワン株式会社 試薬・プロセス材料グループ
- TEL：06-6447-8641
- FAX：06-6447-8642
- E-mail：[email protected]
